Skip to main content

Advertisement

Log in

H. pylori Infection, Inflammation and Gastric Cancer

  • Review Article
  • Published:
Journal of Gastrointestinal Cancer Aims and scope Submit manuscript

Abstract

Introduction

A strong association between chronic infection, inflammation, and cancer has been suggested.

Discussion

Helicobacter pylori, a microaerophilic gram negative bacterium, infects about half the world’s population. It has been defined as a definitive carcinogen in the pathogenesis of gastric cancer. H. pylori evades the host immune responses and persists in the stomach leading to gastritis gastric atrophy and sometimes gastric cancer.

Conclusion

Chronic H. pylori infection causes gastric cancer via two mechanisms: the presence of virulence factors and the induction of chronic inflammation which ultimately leads to neoplastic transformation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860–7.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  2. Shacter E, Weitzman SA. Chronic inflammation and cancer. Oncology. 2002;16:217–26.

    PubMed  Google Scholar 

  3. Hussain SP, Hofseth LJ, Harris CC. Radical causes of cancer. Nat Rev Cancer. 2003;3:276–85.

    Article  CAS  PubMed  Google Scholar 

  4. Zarrilli R, Ricci V, Romano M. Molecular response of gastric epithelial cells to Helicobacter pylori-induced cell damage. Cell Microbiol. 1999;1:93–9.

    Article  CAS  PubMed  Google Scholar 

  5. Hessey SJ, Spencer J, Wyatt JI, Sobala G, Rathbone BJ, Axon AT, et al. Bacterial adhesion and disease activity in Helicobacter associated chronic gastritis. Gut. 1990;31:134–8.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. Solnick JV, Hansen LM, Salama NR, Boonjakuakul JK, Syvanen M. Modification of Helicobacter pylori outer membrane protein expression during experimental infection of rhesus macaques. Proc Natl Acad Sci U S A. 2004;101:2106–11.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  7. Franco AT, Johnston E, Krishna U, Yamaoka Y, Israel DA, Nagy TA, et al. Regulation of gastric carcinogenesis by Helicobacter pylori virulence factors. Cancer Res. 2008;68:379–87.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. Segal ED, Lange C, Covacci A, Tompkins LS, Falkow S. Induction of host signal transduction pathways by Helicobacter pylori. Proc Natl Acad Sci U S A. 1997;94:7595–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Suerbaum S. Genetic variability within Helicobacter pylori. Int J Med Microbiol. 2000;290:175–81.

    Article  CAS  PubMed  Google Scholar 

  10. Weeks DL, Eskandari S, Scott DR, Sachs GA. H+-gated urea channel: the link between Helicobacter pylori urease and gastric colonization. Science. 2000;287:482–5.

    Article  CAS  PubMed  Google Scholar 

  11. Perez-Perez GI, Shepherd VL, Morrow JD, Blaser MJ. Activation of human THP-1 cells and rat bone marrow-derived macrophages by Helicobacter pylori lipopolysaccharide. Infect Immun. 1995;63:1183–7.

    CAS  PubMed Central  PubMed  Google Scholar 

  12. Reeves EP, Ali T, Leonard P, Hearty S, O’Kennedy R, May FE, et al. Helicobacter pylori lipopolysaccharide interacts with TFF1 in a pH-dependent manner. Gastroenterology. 2008;135:2043–54.

    Article  CAS  PubMed  Google Scholar 

  13. Axsen WS, Styer CM, Solnick JV. Inhibition of heat shock protein expression by Helicobacter pylori. Microb Pathog. 2009;47:231–6.

    Article  CAS  PubMed  Google Scholar 

  14. Alm RA, Ling LS, Moir DT, King BL, Brown ED, Doig PC, et al. Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature. 1999;397:176–80.

    Article  PubMed  Google Scholar 

  15. Naito Y, Yoshikawa T. Molecular and cellular mechanisms involved in Helicobacter pylori-induced inflammation and oxidative stress. Free Radic Biol Med. 2002;33:323–36.

    Article  CAS  PubMed  Google Scholar 

  16. Hatakeyama M. Helicobacter pylori CagA—a bacterial intruder conspiring gastric carcinogenesis. Int J Cancer. 2006;119:1217–23.

    Article  CAS  PubMed  Google Scholar 

  17. Higashi H, Tsutsumi R, Fujita A, Yamazaki S, Asaka M, Azuma T, et al. Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc Natl Acad Sci U S A. 2002;99:14428–33.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  18. Azuma TA, Yamakawa S, Yamazaki K, Fukuta M, Ohtani Y, Ito M, et al. Correlation between variation of the 3_ region of the cagA gene in Helicobacter pylori and disease outcome in Japan. J Infect Dis. 2002;186:1621–30.

    Article  CAS  PubMed  Google Scholar 

  19. Keates S, Keates AC, Warny M, Peek Jr RM, Murray PG, Kelly CP. Differential activation of mitogen-activated protein kinases in AGS gastric epithelial cells by cag+ and cag− Helicobacter pylori. J Immunol. 1999;163:5552–9.

    CAS  PubMed  Google Scholar 

  20. Higashi H, Tsutsumi R, Muto S, Sugiyama T, Azuma T, Asaka M, et al. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science. 2002;295:683–6.

    Article  CAS  PubMed  Google Scholar 

  21. De Souza D, Fabri LJ, Nash A, Hilton DJ, Nicola NA, Baca M. SH2 domains from suppressor of cytokine signaling-3 and protein tyrosine phosphatase SHP-2 have similar binding specificities. Biochemistry. 2002;41:9229–36.

    Article  PubMed  Google Scholar 

  22. Tsutsumi R, Higashi H, Higuchi M, Okada M, Hatakeyama M. Attenuation of Helicobacter pylori CagA SHP-2 signaling by interaction between CagA and C-terminal Src kinase. J Biol Chem. 2003;278:3664–70.

    Article  CAS  PubMed  Google Scholar 

  23. Backert S, Moese S, Selbach M, Brinkmann V, Meyer TF. Phosphorylation of tyrosine 972 of the Helicobacter pylori CagA protein is essential for induction of a scattering phenotype in gastric epithelial cells. Mol Microbiol. 2001;42:631–44.

    Article  CAS  PubMed  Google Scholar 

  24. Neel BG, Gu H, Pao L. The ‘Shp’ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. Trends Biochem Sci. 2003;28:284–93.

    Article  CAS  PubMed  Google Scholar 

  25. Suerbaum S, Josenhans C, Claus H, Frosch M. Bacterial genomics: seven years on. Trends Microbiol. 2002;10:351–3.

    Article  CAS  PubMed  Google Scholar 

  26. Stein M, Rappuoli R, Covacci A. Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cag-driven host cell translocation. Proc Natl Acad Sci U S A. 2000;97:1263–8.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  27. Moese S, Selbach M, Brinkmann V, Karlas A, Haimovich B, Backert S, et al. The Helicobacter pylori CagA protein disrupts matrix adhesion of gastric epithelial cells by dephosphorylation of vinculin. Cell Microbiol. 2007;9:1148–61.

    Article  CAS  PubMed  Google Scholar 

  28. Selbach M, Moese S, Backert S, Jungblut PR, Meyer TF. The Helicobacter pylori CagA protein induces tyrosine dephosphorylation of ezrin. Proteomics. 2004;4:2961–8.

    Article  CAS  PubMed  Google Scholar 

  29. Churin Y, Al-Ghoul L, Kepp O, Meyer TF, Birchmeier W, Naumann M. Helicobacter pylori CagA protein targets the c-Met receptor and enhances the motogenic response. J Cell Biol. 2003;161:249–55.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  30. Mimuro H, Suzuki T, Tanaka J, Asahi M, Haas R, Sasakawa C. Grb2 is a key mediator of Helicobacter pylori CagA protein activities. Mol Cell. 2002;10:745–55.

    Article  CAS  PubMed  Google Scholar 

  31. Cheng AM, Saxton TM, Sakai R, Kulkarni S, Mbamalu G, Vogel W, et al. Mammalian Grb2 regulates multiple steps in embryonic development and malignant transformation. Cell. 1998;95:793–803.

    Article  CAS  PubMed  Google Scholar 

  32. Fodde R, Brabletz T. Wnt/b-catenin signaling in cancer stemness and malignant behavior. Curr Opin Cell Biol. 2007;19:150–8.

    Article  CAS  PubMed  Google Scholar 

  33. Hoppler S, Kavanagh CL. Wnt signalling: variety at the core. J Cell Sci. 2007;120:385–93.

    Article  CAS  PubMed  Google Scholar 

  34. Brandt S, Kwok T, Hartig R, König W, Backert S. NFkB activation and potentiation of proinflammatory responses by the Helicobacter pylori CagA protein. Proc Natl Acad Sci U S A. 2005;102:9300–5.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  35. Peek Jr RM, Vaezi MF, Falk GW, Goldblum JR, Perez-Perez GI, Richter JE, et al. Role of Helicobacter pylori cagA(+) strains and specific host immune responses on the development of premalignant and malignant lesions in the gastric cardia. Int J Cancer. 1999;82:520–4.

    Article  PubMed  Google Scholar 

  36. Kuck D, Kolmerer B, Iking-Konert C, Krammer PH, Stremmel W, Rudi J. Vacuolating cytotoxin of Helicobacter pylori induces apoptosis in the human gastric epithelial cell line AGS. Infect Immun. 2001;69:5080–7.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  37. Peek Jr RM. Helicobacter pylori strain-specific modulation of gastric mucosal cellular turnover: implications for carcinogenesis. J Gastroenterol. 2002;37 Suppl 13:10–6.

    Article  CAS  PubMed  Google Scholar 

  38. Atherton JC, Cao P, Peek M, Tummuru MK, Blaser MJ, Cover TL. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori: association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem. 1995;270:17771–7.

    Article  CAS  PubMed  Google Scholar 

  39. Figueiredo C, Van Doorn LJ, Nogueira C, Soares JM, Pinho C, Figueira P, et al. Helicobacter pylori genotypes are associated with clinical outcome in Portuguese patients and show a high prevalence of infections with multiple strains. Scand J Gastroenterol. 2001;36:128–35.

    Article  CAS  PubMed  Google Scholar 

  40. Rhead JL, Letley DP, Mohammadi M, Hussein N, Mohagheghi MA, Eshagh Hosseini M, et al. A new Helicobacter pylori vacuolating cytotoxin determinant, the intermediate region, is associated with gastric cancer. Gastroenterology. 2007;133:926–36.

    Article  CAS  PubMed  Google Scholar 

  41. Torres VJ, VanCompernolle SE, Sundrud MS, Unutmaz D, Cover TL. Helicobacter pylori vacuolating cytotoxin inhibits activation-induced proliferation of human T and B lymphocyte subsets. J Immunol. 2007;179(8):5433–40.

    Article  CAS  PubMed  Google Scholar 

  42. Menaker RJ, Ceponis PJM, Jones NL. Helicobacter pylori induces apoptosis of macrophages in association with alterations in the mitochondrial pathway. Infect Immun. 2004;72(5):2889–98.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  43. Zheng PY, Jones NL. Helicobacter pylori strains expressing the vacuolating cytotoxin interrupt phagosome maturation in macrophages by recruiting and retaining TACO (coronin 1) protein. Cell Microbiol. 2003;5(1):25–40.

    Article  CAS  PubMed  Google Scholar 

  44. Schmees C, Prinz C, Treptau T, et al. Inhibition of T-cell proliferation by Helicobacter pylori gamma-glutamyl transpeptidase. Gastroenterology. 2007;132(5):1820–33.

    Article  CAS  PubMed  Google Scholar 

  45. Zabaleta J, McGee DJ, Zea AH, et al. Helicobacter pylori arginase inhibits T cell proliferation and reduces the expression of the TCR zeta-chain (CD3zeta). J Immunol. 2004;173(1):586–93.

    Article  CAS  PubMed  Google Scholar 

  46. Gobert P, McGee DJ, Akhtar M, et al. Helicobacter pylori arginase inhibits nitric oxide production by eukaryotic cells: a strategy for bacterial survival. Proc Natl Acad Sci U S A. 2001;98(24):13844–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  47. Yuan J, Li P, Tao J, et al. H. pylori escape host immunoreactions through inhibiting ILK expression by VacA. Cell Mol Immunol. 2009;6(3):191–7.

    Article  CAS  PubMed  Google Scholar 

  48. Everhart JE. Recent developments in the epidemiology of Helicobacter pylori. Gastroenterol Clin North Am. 2000;29:559–78.

    Article  CAS  PubMed  Google Scholar 

  49. Peek Jr RM, Blaser MJ. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer. 2002;2:28–37.

    Article  CAS  PubMed  Google Scholar 

  50. El-Omar EM, Rabkin CS, Gammon MD, Vaughan TL, Risch HA, Schoenberg JB, et al. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology. 2003;124:1193–201.

    Article  CAS  PubMed  Google Scholar 

  51. Hansson LE, Nyren O, Hsing AW, Bergstrom R, Josefsson S, Chow WH, et al. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med. 1996;335:242–9.

    Article  CAS  PubMed  Google Scholar 

  52. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345:784–9.

    Article  CAS  PubMed  Google Scholar 

  53. Mannick EE, Bravo LE, Zarama G, Realpe JL, Zhang XJ, Ruiz B, et al. Inducible nitric oxide synthase, nitrotyrosine, and apoptosis in Helicobacter pylori gastritis: effect of antibiotics and antioxidants. Cancer Res. 1996;56:3238–43.

    CAS  PubMed  Google Scholar 

  54. Jaiswal M, LaRusso NF, Gores GJ. Nitric oxide in gastrointestinal epithelial cell carcinogenesis: linking inflammation to oncogenesis. Am J Physiol Gastrointest Liver Physiol. 2001;281:G626–34.

    CAS  PubMed  Google Scholar 

  55. Salvemini D, Misko TP, Masferrer JL, Seibert K, Currie MG, Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci U S A. 1993;90:7240–4.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  56. Sung JJ, Leung WK, Go MY, To KF, Cheng AS, Ng EK, et al. Cyclooxygenase-2 expression in Helicobacter pylori-associated premalignant and malignant gastric lesions. Am J Pathol. 2000;157:729–35.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  57. Dubois RN, Abramson SB, Crofford L, Gupta RA, Simon LS, Van De Putte LB, et al. Cyclooxygenase in biology and disease. FASEB J. 1998;12:1063–73.

    CAS  PubMed  Google Scholar 

  58. Sharma SA, Tummuru MK, Blaser MJ, Kerr LD. Activation of IL-8 gene expression by Helicobacter pylori is regulated by transcription factor nuclear factor-kappa B in gastric epithelial cells. J Immunol. 1998;160:2401–7.

    CAS  PubMed  Google Scholar 

  59. Hatz RA, Rieder G, Stolte M, Bayerdorffer E, Meimarakis G, Schildberg FW, et al. Pattern of adhesion molecule expression on vascular endothelium in Helicobacter pylori associated antral gastritis. Gastroenterology. 1997;112:1908–19.

    Article  CAS  PubMed  Google Scholar 

  60. Mazzucchelli L, Blaser A, Kappeler A, et al. BCA-1 is highly expressed in Helicobacter pylori-induced mucosa-associated lymphoid tissue and gastric lymphoma. J Clin Invest. 1999;104:R49–54.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  61. Medzhitov R, Preston-Hurlburt P, Janeway Jr CA. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature. 1997;388:394–7.

    Article  CAS  PubMed  Google Scholar 

  62. Kawai T, Takeuchi O, Fujita T, Inoue J, Muhlradt PF, Sato S, et al. Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J Immunol. 2001;167:5887–94.

    Article  CAS  PubMed  Google Scholar 

  63. Gasperini S, Marchi M, Calzetti F, Laudanna C, Vicentini L, Olsen H, et al. Gene expression and production of the monokine induced by IFN-gamma (MIG), IFN-inducible T cell alpha chemoattractant (ITAC), and IFN-gamma-inducible protein-10 (IP-10) chemokines by human neutrophils. J Immunol. 1999;162:4928–37.

    CAS  PubMed  Google Scholar 

  64. Bogdan C. Nitric oxide and the immune response. Nat Immunol. 2001;2:907–16.

    Article  CAS  PubMed  Google Scholar 

  65. Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthases: structure, function and inhibition. Biochem J. 2001;357:593–615.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  66. Benelli R, Morini M, Carrozzino F, Ferrari N, Minghelli S, Santi L, et al. Neutrophils as a key cellular target for angiostatin: implications for regulation of angiogenesis and infl ammation. FASEB J. 2002;16:267–9.

    CAS  PubMed  Google Scholar 

  67. Renshaw M, Rockwell J, Engleman C, Gewirtz A, Katz J, Sambhara S. Cutting edge: impaired Toll-like receptor expression and function in aging. J Immunol. 2002;169:4697–701.

    Article  CAS  PubMed  Google Scholar 

  68. Petersson C, Forsberg M, Aspholm M, et al. Helicobacter pylori SabA adhesin evokes a strong inflammatory response in human neutrophils which is down-regulated by the neutrophil-activating protein. Med Microbiol Immunol. 2006;195(4):195–206.

    Article  CAS  PubMed  Google Scholar 

  69. Battan M, Raviglione C, Palagiano A, et al. Helicobacter pylori infection in patients with acquired immune deficiency syndrome. Am J Gastroenterol. 1990;85(12):1576–9.

    CAS  PubMed  Google Scholar 

  70. Wunder C, Churin Y, Winau F. Cholesterol glucosylation promotes immune evasion by Helicobacter pylori. Nat Med. 2006;12(9):1030–8.

    Article  CAS  PubMed  Google Scholar 

  71. Ringnér M, Valkonen RK, Wadström T. Binding of vitronectin and plasminogen to Helicobacter pylori. FEMS Immunol Med Microbiol. 1994;9(1):29–34.

    PubMed  Google Scholar 

  72. Andersen-Nissen E, Smith KD, Strobe KL, et al. Evasion of Toll-like receptor 5 by flagellated bacteria. Proc Natl Acad Sci U S A. 2005;102(26):9247–52.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  73. Gewirtz T, Yu Y, Krishna US, Israel DA, Lyons SL, Peek RM. Helicobacter pylori flagellin evades toll-like receptor 5-mediated innate immunity. J Infect Dis. 2004;189(10):1914–20.

    Article  CAS  PubMed  Google Scholar 

  74. Lee SK, Stack A, Katzowitsch E, Aizawa SI, Suerbaum S, Josenhans C. Helicobacter pylori flagellins have very low intrinsic activity to stimulate human gastric epithelial cells via TLR5. Microbes Infect. 2003;5(15):1345–56.

    Article  CAS  PubMed  Google Scholar 

  75. Karin M et al. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol. 2005;5:749–59.

    Article  CAS  PubMed  Google Scholar 

  76. Mantovani A et al. Cancer-related inflammation. Nature. 2008;454:436–44.

    Article  CAS  PubMed  Google Scholar 

  77. Westbrook AM et al. Mechanisms of intestinal inflammation and development of associated cancers: lessons learned from mouse models. Mutat Res. 2010;705:40–59.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  78. Grivennikov SI et al. Immunity, inflammation, and cancer. Cell. 2010;140:883–99.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  79. Hahn MA et al. Methylation of polycomb target genes in intestinal cancer is mediated by inflammation. Cancer Res. 2008;68:10280–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  80. Popivanova BK et al. Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. J Clin Invest. 2008;118:560–70.

    CAS  PubMed Central  PubMed  Google Scholar 

  81. Kim YJ et al. Prevention of colitis-associated carcinogenesis with infliximab. Cancer Prev Res (Phila). 2010;3:1314–33.

    Article  CAS  Google Scholar 

  82. Correa P. Chronic gastritis: a clinico-pathological classification. Am J Gastroenterol. 1988;83(5):504–9.

    CAS  PubMed  Google Scholar 

  83. Correa P, Cuello C, Duque E, et al. Gastric cancer in Colombia. III. Natural history of precursor lesions. J Natl Cancer Inst. 1976;57(5):1027–35.

    CAS  PubMed  Google Scholar 

  84. Cuello C, Correa P, Haenszel W, et al. Gastric cancer in Colombia. I. Cancer risk and suspect environmental agents. J Natl Cancer Inst. 1976;57(5):1015–20.

    CAS  PubMed  Google Scholar 

  85. Haenszel W, Correa P, Cuello C, et al. Gastric cancer in Colombia. II. Case control epidemiologic study of precursor lesions. J Natl Cancer Inst. 1976;57(5):1021–6.

    CAS  PubMed  Google Scholar 

  86. Correa P, Haenszel W, Cuello C, et al. Gastric precancerous process in a high risk population: cohort follow-up. Cancer Res. 1990;50(15):4737–40.

    CAS  PubMed  Google Scholar 

  87. Correa P, Piazuelo MB. The gastric precancerous cascade. J Dig Dis. 2012;13(1):2–9.

    Article  PubMed Central  PubMed  Google Scholar 

  88. Delahay RM, Rugge M. Pathogenesis of Helicobacter pylori infection. Helicobacter. 2012;17(1):9–15.

    CAS  PubMed  Google Scholar 

  89. Gonzalo Carrasco and Alejandro H. Corvalan. Helicobacter pylori-Induced Chronic Gastritis and Assessing Risks for Gastric Cancer. Gastroenterology Res Pract Vol 2013, Article ID 393015, 8 pages doi:10.1155/2013/393015.

Download references

Conflict of interest

All the authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zafar A. Shah.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Qadri, Q., Rasool, R., Gulzar, G.M. et al. H. pylori Infection, Inflammation and Gastric Cancer. J Gastrointest Canc 45, 126–132 (2014). https://doi.org/10.1007/s12029-014-9583-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12029-014-9583-1

Keywords

Navigation